Felbamate urolithiasis

Epilepsia

Volumn 42, Issue 5, 2001, Pages 682-685

  Sparagana, S P ^a,c,d   Strand, W R ^b,c   Adams, R C ^a,c  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d NONE   (United States)

Author keywords

Adverse drug event; Crystalluria; Drug urolithiasis; Felbamate

Indexed keywords

FELBAMATE;

ADOLESCENT; ARTICLE; CASE REPORT; CHEMICAL ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CRYSTALLURIA; CYSTOSCOPY; DIAGNOSTIC IMAGING; EPILEPSY; HEMATURIA; HUMAN; INTRAVENOUS PYELOGRAPHY; MALE; MICTURITION CYSTOURETHROGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STENT; URETER OBSTRUCTION; URINE RETENTION; UROGRAPHY; UROLITHIASIS;

ADOLESCENT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; EPILEPSY; HUMANS; MALE; PROPYLENE GLYCOLS; RISK FACTORS; SPECTROPHOTOMETRY, INFRARED; URINARY CALCULI;

EID: 0035000330     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.32500.x     Document Type: Article

References (15)

1. Paisley KE, Tomson CRV. Calcium phosphate stones during longterm acetazolamide treatment for epilepsy. Postgrad Med J 1999; 75:427-8.
2. Glauser TA. Topiramate. Semin Pediatr Neurol 1997;4:34-42.
3. Leppik IE, Willmore LJ, Homan RW, et al. Efficacy and safety of zonisamide: results of a multicenter study. Epilepsy Res 1993;14: 165-73.
4. Oommen KJ, Mathews S. Zonisamide: a new antiepileptic drug. Clin Neuropharmacol 1999;22:192-200.
5. Daudon M, Reveillaud RJ. Drug nephrolithiasis: an unrecognized and underestimated pathology. In: Schwille PO, Smith LH, Robertson WG, Vahlensieck W. eds. Urolithiasis and related clinical research. New York: Plenum Press, 1984:371-4.
6. Rapado A, Traha ML, Caycho C, et al. Drug induced renal stones: incidence, clinical expression and stone analysis. Contrib Nephrol 1987;58:25-9.
7. Tsao JW, Kogan SC. Indinavir crystalluria. N Engl J Med 1999; 340:1329.
8. Powell T, Hsu FF, Turk J, et al. Ma-huang strikes again: ephedrine nephrolithiasis. Am J Kidney Dis 1998;32:153-9.
9. Cochat P, Cochat N, Jouvenet M, et al. Ceftriaxone-associated nephrolithiasis. Nephrol Dial Transplant 1990;5:974-6.
10. Ramsay LE. Methyldopa and renal stones: a retrospective study. Med J Aust 1997;2:495-7.
11. Wallace Laboratories. Felbatol (felbamate). Package insert, 1999.
12. Palmer KJ, McTavish D. Felbamate: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy. Drug Eval 1993;45:1041-65.
13. Leppik IE. Felbamate. Epilepsia 1995;36(suppl 2):S66-72.
14. Pellock JM. Utilization of new antiepileptic drugs in children. Epilepsia 1996;37(suppl 1):S66-73.
15. Pellock JM, Brodie MJ. Felbamate: 1997 update. Epilepsia 1997; 38:1261-4.